Streetbeat News

UPC

Universe Pharmaceuticals INC

Industry

Drug Manufacturers - Specialty & Generic

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Open

0.83

Mkt cap

1.6M

Volume

437K

High

0.83

P/E Ratio

-0.01

52-wk high

64.80

Low

0.68

Div yield

N/A

52-wk low

0.68

Univest Securities, LLC has closed a $15 million registered direct offering for Universe Pharmaceuticals INC (NASDAQ: UPC), a pharmaceutical company in China.

Portfolio Pulse from

December 10, 2024 | 10:15 pm

Universe Pharmaceuticals INC (NASDAQ:UPC) has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, as its share price has fallen below $1.00 for 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:02 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. VSee Health (VSEE) saw a notable increase of 66.5%, while GRI Bio (GRI) rose by 21.58%. On the downside, SAB Biotherapeutics (SABS) fell by 7.8%, and Healthcare Triangle (HCTI) decreased by 7.21%.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 8:31 pm

The article highlights significant intraday movements in healthcare stocks, with notable gainers including 180 Life Sciences, Korro Bio, and Universe Pharmaceuticals, and losers such as Novavax and Tevogen Bio Holdings.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 4:31 pm

Universe Pharmaceuticals shares have been halted after experiencing an 11.80% increase in their stock price.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 4:26 pm

The article reports on the intraday movements of several healthcare stocks. Notable gainers include NewGenIvf Group, Universe Pharmaceuticals, and Pacific Biosciences, while Perspective Therapeutics, Protagenic Therapeutics, and Regencell Bioscience are among the losers.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:31 pm

Several healthcare stocks experienced significant price movements in Friday's pre-market session. Mural Oncology, Universe Pharmaceuticals, Biodesix, Allakos, SCWorx, and aTyr Pharma saw notable gains, while Avinger, Renovaro, Sage Therapeutics, Chromocell Therapeutics, Reshape Lifesciences, and BioCardia experienced declines.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 12:07 pm

Exicure, Inc. (NASDAQ:XCUR) shares surged over 49% in pre-market trading after the company entered into debt-for-equity exchange agreements and regained Nasdaq compliance. Other notable pre-market movers include NuCana plc (NASDAQ:NCNA) with a 94.4% gain due to positive Phase 2 study data, and Dermata Therapeutics, Inc. (NASDAQ:DRMA) rising 73.4%. On the downside, Rafael Holdings, Inc. (NYSE:RFL) fell 40.1% after previous gains.

Portfolio Pulse from Avi Kapoor

September 16, 2024 | 10:07 am

U.S. stocks rose with the Dow Jones up over 400 points. Adobe shares fell 9% after Q3 results. Tenon Medical, Singular Genomics, and Agape ATP saw significant gains due to various announcements. Universe Pharmaceuticals and Garden Stage Limited experienced major declines.

Portfolio Pulse from Avi Kapoor

September 13, 2024 | 4:15 pm

Universe Pharmaceuticals shares have resumed trading after a temporary halt. This development may influence investor sentiment and trading activity in the short term.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 5:04 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.